Eyes have been inspiring humans for thousands of years; let us take care of them
SINGAPORE and LONDON (PRWEB) November 02, 2018
As per World Health Organization, about 1.3 million people are suffering from some form of visual impairment, of which about 80% cases are considered avoidable. Refractive errors and cataracts are the leading causes of vision impairment which can be rectified with the usage of corrective lenses or by an ophthalmology procedure. Ophthalmology is one of the most revered and prestigious fields in medicine as it confers vision to the patients. It encompasses visual analysis, restoration of good sight by lenses and corneal surgeries.
The global market potential for ophthalmic diagnostic and monitoring devices, surgical instruments and vision products is estimated at $31.2 billion and is projected to grow due to rise in the prevalence of eye disorders such as glaucoma, cataract, macular degeneration, diabetic retinopathy etc. The United States, Western Europe, Japan, and China are the major source of ophthalmic revenues. Global Ophthalmic Drugs Market size was valued at $29,613 million in 2016, and is expected to reach $42,663 million by 2023, registering a compound annual growth rate (CAGR) of 5.3% from 2017 to 2023. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. The Global Ophthalmology and Optometry pipeline review, H2 2018 estimates the market to grow at a CAGR of 4.12% during the period 2018 to 2022. A report by Transparency Market Research projects the global optometry market to rise at CAGR of 4.1% from 2017 to 2025 to become worth $79.871 billion by the year 2025 from $55.974 billion in 2016. With the increase in the demand for vision care, innovations and advancements, ophthalmology is becoming highly sought after.
On a world-wide basis there are about 29 ophthalmologists per million people. Only about 60% of all ophthalmologists are performing surgeries while residents constitute 10% who are entering practice at the rate of 2.4%. There is a general shortage for the specialists to treat various newly emerging disorders. Therefore, it becomes essential to connect the experienced professionals to the prospective ophthalmologists to impart their knowledge. Apart from this, boosting the research and bridging the gap between academic researchers and clinicians would also help a great deal in mitigating visual disorders. In this context, Ophthalmology conferences aim to draw the attention of the eminent clinical professionals of Ophthalmology to address the concerns, queries and send the message across to the future generation to a society free of blindness.
Dr. Srinubabu Gedela, the CEO of Pulsus and Omics International opines that scientific conferences are the bedrock of research as they open scientific works to constructive criticism. He has emphasized that these conferences are a perfect platform to share experience, foster collaborations across industry and academia.
Conference series is delighted to announce the Ophthalmology Conferences in 2019. These ophthalmology conferences are a rich mix of Interactive Sessions, keynote lectures, panel discussions, and poster competitions.
The 2019 Ophthalmology Conferences would deal with some very important topics in the field, such as neuro-ophthalmology, optometry, and pediatric ophthalmology.
We welcome our esteemed delegates on board for our upcoming conferences on Ophthalmology in the year 2019.